Thursday, July 18, 2013
GlaxoSmithKline plc and the University of California have reconciled their differences related to whether
researchers at the 10-campus system can participate in GSK's Discovery Fast
Track program. The University of California technology transfer offices will
now vet applications for potentially sensitive disclosures before the pharma
lays eyes on them.
L. SciBX 6(27);
doi:10.1038/scibx.2013.674 Published online July 18, 2013
1. Osherovich, L. SciBX
2. Osherovich, L. SciBX
AND INSTITUTIONS MENTIONED
GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K.
University of California, Oakland, Calif.
University of California, Los Angeles, Calif.